In the early stage, the study was made on laboratory rodents with artificial signs of dementia. After the treatment process in animals, learning developed and the analysis of brain tissue showed a significant decrease in the number of protein deposits of amyroid plaques associated with neurodegenerative processes.
According to developers, this drug does not have analogues at the moment. Existing tools such as cerebroliz can cause strong immune reactions because they are produced from animal tissues. Other approaches – for example, the use of antibodies or inhibitors – did not show sufficient efficiency in the clinical test phase.
The new tool is basically distinguished by a different mechanism of action. Unlike drugs that partially eliminate symptoms, it is directed towards the causes of the disease.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
